Nuvation Bio Inc. Class A Common Stock vs Principal Financial Group Inc Common Stock — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $5.01 (market cap $1.74B), while Principal Financial Group Inc Common Stock trades at $107.43 (market cap $23.51B). The key difference: Principal Financial Group Inc Common Stock is far larger — about 13.5× Nuvation Bio Inc. Class A Common Stock's market cap, and Principal Financial Group Inc Common Stock pays a 3.06% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 1 Days and Principal Financial Group Inc Common Stock for 1 Days on average.
| NUVB | PFG | |
|---|---|---|
Market Cap | $1.74B | $23.51B |
Volume | 9,289,619 | 1,118,505 |
Sector | Health | Financials |
52-Week High | $9.54 | $118.51 |
52-Week Low | $3.41 | $78.39 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $1.33B | $22.59B |
Dividend Yield | — | 3.06% |
Trailing returns across standard periods
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →Principal Financial Group provides retirement, insurance, and asset management services. It serves individuals, employers, and institutional clients.
Read more on PFG →